# Ocugen, Inc.: Form 8-K, filed Oct 15, 2026

- Company: [Ocugen, Inc.](/companies/ocgn.md) (CIK 1372299)
- Form: 8-K
- Filed: 2026-10-15
- Accepted by EDGAR: Oct 14, 2026, 21:22 ET
- Period: 2026-10-13
- Accession: 0001104659-26-115921
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1372299/000110465926115921/tm2627592d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372299/000110465926115921/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372299/000110465926115921/tm2627592d1_8k.htm

Filed Oct 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-115921. Last ingested by Listed: Nov 10, 2026, 17:14 ET. No prices; not investment advice.
